NCI Director Kimryn Rathmell shared advice for the next generation of cancer researchers with members of the AACR Associate...
Early detection is key to improving outcomes from cancer. Shifting the focus even earlier in the natural history of...
An individual with hypertension visits their primary care physician and learns that two new medications for their condition have...
The AACR Annual Meeting 2023 set a new record this year with the number of clinical trial abstracts submitted...
Although not common, a cancer diagnosis during pregnancy or the onset of a pregnancy while a woman is receiving...
Earlier this month, over 21,000 researchers, clinicians, patients, and other stakeholders gathered at the AACR Annual Meeting 2023 to...
Historically, most cancer drugs have been tested separately in adults and children. For the approval of new drugs for...
“Are you ready to have a great meeting?” Robert Vonderheide, MD, DPhil, asked the nearly 11,000 attendees gathered in...
When Monica Bertagnolli, MD, was appointed director of the National Cancer Institute in 2022, she became the first woman...
The 2015 approval of an immune checkpoint inhibitor for renal cell carcinoma (RCC) provided a much-needed new treatment option...
The plenary program of the AACR Annual Meeting 2023 kicked off Saturday, April 15, with a session titled “Beating...